Safety and immunologic correlates of Melanoma GVAX, a GM-CSF secreting allogeneic melanoma cell vaccine administered in the adjuvant setting

被引：0
|
作者：
Evan J Lipson
William H Sharfman
Shuming Chen
Tracee L McMiller
Theresa S Pritchard
January T Salas
Susan Sartorius-Mergenthaler
Irwin Freed
Sowmya Ravi
Hao Wang
Brandon Luber
Janice Davis Sproul
Janis M Taube
Drew M Pardoll
Suzanne L Topalian
机构：
[1] Johns Hopkins University School of Medicine and Sidney Kimmel Comprehensive Cancer Center,Department of Oncology
[2] Johns Hopkins University School of Medicine and Sidney Kimmel Comprehensive Cancer Center,Department of Oncology
[3] Johns Hopkins University School of Medicine and Sidney Kimmel Comprehensive Cancer Center,Department of Surgery
[4] Johns Hopkins University School of Medicine and Sidney Kimmel Comprehensive Cancer Center,Department of Dermatology
[5] Johns Hopkins University School of Medicine and Sidney Kimmel Comprehensive Cancer Center,Division of Biostatistics and Bioinformatics, Department of Oncology
[6] Johns Hopkins University School of Medicine and Sidney Kimmel Comprehensive Cancer Center,Department of Pathology
来源：
Journal of Translational Medicine | / 13卷
关键词：
Melanoma; Vaccine; Immunotherapy; Adjuvant; GM-CSF;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 31 条
  • [21] Gene gun transfection of human glioma and melanoma cell lines with genes encoding human IL-12 and GM-CSF
    Gainer, AL
    Young, ATL
    Parney, IF
    Petruk, KC
    Elliott, JF
    JOURNAL OF NEURO-ONCOLOGY, 2000, 47 (01) : 23 - 30
  • [22] Successful induction of immune responses against mutant ras in melanoma patients using intradermal injection of peptides and GM-CSF as adjuvant
    Hunger, RE
    Brand, CU
    Streit, M
    Eriksen, JA
    Gjertsen, MK
    Saeterdal, I
    Braathen, LR
    Gaudernack, G
    EXPERIMENTAL DERMATOLOGY, 2001, 10 (03) : 161 - 167
  • [23] GM-CSF-surface-modified B16.F10 melanoma cell vaccine
    Gao, Jimin
    Huang, Shuqi
    Li, Ming
    Luo, Rongcheng
    Wang, Xiaoning
    Takashima, Akira
    VACCINE, 2006, 24 (25) : 5265 - 5268
  • [24] Phase I/II trial of melanoma patient-speciric vaccine of proliferating autologous tumor cells, dendritic cells, and GM-CSF: Planned interim analysis
    Dillman, R
    Selvan, S
    Schiltz, P
    Peterson, C
    Allen, K
    DePriest, C
    McClay, E
    Barth, N
    Sheehy, P
    de Leon, C
    Beutel, L
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2004, 19 (05) : 658 - 665
  • [25] Enhancing therapy of B16F10 melanoma efficacy through tumor vaccine expressing GPI-anchored IL-21 and secreting GM-CSF in mouse model
    Zhao, Fengshu
    Dou, Jun
    He, Xiang Feng
    Wang, Jing
    Chu, Lili
    Hu, Weihua
    Yu, Fangliu
    Hu, Kai
    Wu, Yun
    Gu, Ning
    VACCINE, 2010, 28 (16) : 2846 - 2852
  • [26] A bystander cell-based GM-CSF secreting vaccine synergized with a low dose of cyclophosphamide presents therapeutic immune responses against murine hepatocellular carcinoma
    Chen, Chen
    Hou, Jiajie
    Lin, Zhe
    Yao, Ming
    Jiang, Runqiu
    Wang, Youjing
    Gao, Yun
    Shao, Qing
    Deng, Lei
    Chen, Yun
    Sun, Beicheng
    CELLULAR & MOLECULAR IMMUNOLOGY, 2013, 10 (04) : 349 - 359
  • [27] Treatment with GM-CSF Secreting Myeloid Leukemia Cell Vaccine Prior to Autologous-BMT Improves the Survival of Leukemia-Challenged Mice
    Zilberberg, Jenny
    Friedman, Thea M.
    Dranoff, Glenn
    Korngold, Robert
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (03) : 330 - 340
  • [28] Anti-melanoma vaccinal capacity of CD11c-positive and -negative cell populations present in GM-CSF cultures derived from murine bone marrow precursors
    Campisano, Sabrina
    Mac Keon, Soledad
    Gazzaniga, Silvina
    Sol Ruiz, Maria
    Dodes Traian, Martin
    Mordoh, Jose
    Wainstok, Rosa
    VACCINE, 2013, 31 (02) : 354 - 361
  • [29] A bystander cell-based GM-CSF secreting vaccine synergized with a low dose of cyclophosphamide presents therapeutic immune responses against murine hepatocellular carcinoma
    Chen Chen
    Jiajie Hou
    Zhe Lin
    Ming Yao
    Runqiu Jiang
    Youjing Wang
    Yun Gao
    Qing Shao
    Lei Deng
    Yun Chen
    Beicheng Sun
    Cellular & Molecular Immunology, 2013, 10 : 349 - 359
  • [30] Safety and Immunogenicity of Vaccination With MART-1 (26-35, 27L), gp100 (209-217, 210M), and Tyrosinase (368-376, 370D) In Adjuvant With PF-3512676 and GM-CSF In Metastatic Melanoma
    Tarhini, Ahmad A.
    Leng, Siyang
    Moschos, Stergios J.
    Yin, Yan
    Sander, Cindy
    Lin, Yan
    Gooding, William E.
    Kirkwood, John M.
    JOURNAL OF IMMUNOTHERAPY, 2012, 35 (04) : 359 - 366
1234